Skip to main content
Equibles

BARCLAYS PLC

Position in CERS — Cerus Corp

CIK 312069 LONDON, X0
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$649,889
+$156,709 QoQ
Shares Held
222,565
-17.9% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,820,800,481 across 112 Medical Devices names. CERS ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 6,084,725 $476,008,034
2 ABT
Abbott Laboratories
 3,863,474 $350,571,627
3 SYK
Stryker Corp
 805,637 $253,646,750
4 BSX
Boston Scientific Corp
 4,584,260 $195,656,215
5 BIO
Bio-Rad Laboratories, Inc.
 267,634 $78,580,018
6 EW
Edwards Lifesciences Corp
 775,100 $70,115,545
7 DXCM
Dexcom Inc
 999,563 $67,320,565
8 GEHC
GE HealthCare Technologies Inc.
 913,578 $58,478,126

All Filings in CERS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $649,889 222,565
2026-03-31 $493,180 270,979
2025-12-31 $1,834,926 890,741
2025-09-30 $1,782,273 1,120,927
2025-06-30 $2,003,920 1,421,220
2025-03-31 $1,932,485 1,390,277
2024-12-31 $2,279,302 1,480,067
2024-09-30 $2,740,585 1,575,049
2024-06-30 $2,385,317 1,355,294
2024-03-31 $2,684,996 1,420,633
2023-12-31 $3,430,230 1,588,070
2023-09-30 $2,281,482 1,408,323
2023-06-30 $2,918,700 1,186,464
2023-03-31 $1,949,917 656,538
2022-12-31 $332,109 90,989
2022-09-30 $144,463 40,129
2022-06-30 $362,184 68,466
2022-03-31 $371,628 67,692
2021-12-31 $1,616,142 237,319
2021-09-30 $662,238 108,742
2021-06-30 $313,217 52,998
2021-03-31 $825,028 137,276
2020-12-31 $637,864 92,177
2020-09-30 $827,440 132,179
2020-06-30 $856,224 129,731
2020-03-31 $399,807 85,980